Investors

SEC Filing Details

SEC Filing Details

Document Details

Filing Date
Apr 1, 2024
Document Date
Apr 1, 2024
Form Description
Post-effective amendment to an S-8 filing
Filing Group
Registration Statements
Company
Eiger BioPharmaceuticals
Issuer
EIGER BIOPHARMACEUTICALS, INC.